LEVAMISOLE/ANAFASIS, 400 mg/βώλο για αμνούς
LEVAMISOLE/ANAFASIS, 400 mg/βώλο για αμνούς
Authorised
- Levamisole hydrochloride
Product identification
Medicine name:
LEVAMISOLE/ANAFASIS, 400 mg/βώλο για αμνούς
Active substance:
- Levamisole hydrochloride
Target species:
-
Sheep (lamb)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levamisole hydrochloride400.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Sheep (lamb)
-
Meat and offal12dayαμνοί κρεοπαραγωγής
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 53519/07-08-2007/K-0083701
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
